Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H2O4 |
| Molecular Weight | 90.0349 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C(O)=O
InChI
InChIKey=MUBZPKHOEPUJKR-UHFFFAOYSA-N
InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)
| Molecular Formula | C2H2O4 |
| Molecular Weight | 90.0349 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Two-dimensional coordination polymers of copper(II) with oxalate: lattice water control of structure. | 2001-06-04 |
|
| Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. | 2001-06 |
|
| Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. | 2001-06 |
|
| Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy. | 2001-06 |
|
| New methods for the isolation of skeletal muscle sarcolemma and sarcoplasmic reticulum allowing a comparison between the mammalian and amphibian beta(2)-adrenergic receptors and calcium pumps. | 2001-06 |
|
| Effects of hydrochlorothiazide and diet in dogs with calcium oxalate urolithiasis. | 2001-05-15 |
|
| Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR. | 2001-05-15 |
|
| A GTP-dependent vertebrate-type phosphoenolpyruvate carboxykinase from Mycobacterium smegmatis. | 2001-05-11 |
|
| Histological diagnosis of mucopolysaccharidosis IIIA in a wire-haired dachshund. | 2001-05-05 |
|
| Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS. | 2001-05-03 |
|
| Effect of several organic acids on phosphate adsorption by variable charge soils of central China. | 2001-05 |
|
| A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. | 2001-05 |
|
| A critical appraisal of the hypothesis that urine is a saturated equilibrium with respect to stone-forming calcium salts. | 2001-05 |
|
| Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. | 2001-05 |
|
| [Study of renal function in infants diagnosed with renal pyelectasis in the first year of life]. | 2001-05 |
|
| Oxidation of lignin in eucalyptus kraft pulp by manganese peroxidase from Bjerkandera sp. strain BOS55. | 2001-05 |
|
| Mechanisms of wood degradation by brown-rot fungi: chelator-mediated cellulose degradation and binding of iron by cellulose. | 2001-04-27 |
|
| Tooth surface pH during drinking of black tea. | 2001-04-14 |
|
| ESR study of the non-enzymic scission of xyloglucan by an ascorbate-H2O2-copper system: the involvement of the hydroxyl radical and the degradation of ascorbate. | 2001-04 |
|
| Rethinking the role of urinary magnesium in calcium urolithiasis. | 2001-04 |
|
| Urine volume and its effects on renal stone risk in astronauts. | 2001-04 |
|
| Does exhaustive search for microcalcifications improve diagnostic yield in stereotactic core needle breast biopsies? | 2001-04 |
|
| Study of two plants used in traditional medicine in Zimbabwe for skin problems and rheumatism: Dioscorea sylvatica and Urginea altissima. | 2001-04 |
|
| Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. | 2001-03-29 |
|
| Calcium oxalate microdeposition in failing kidney grafts. | 2001-03-27 |
|
| Simultaneous measurement of dopamine and ascorbate at their physiological levels using voltammetric microprobe based on overoxidized poly(1,2-phenylenediamine)-coated carbon fiber. | 2001-03-15 |
|
| The simplest supramolecular complexes containing pairs of Mo(2)(formamidinate)(3) units linked with various dicarboxylates: preparative methods, structures, and electrochemistry. | 2001-03-12 |
|
| Thermally induced changes in metal solubility of contaminated soils is linked to mineral recrystallization and organic matter transformations. | 2001-03-01 |
|
| Hippuric acid as a modifier of calcium oxalate crystallisation. | 2001-03 |
|
| Chitooligosaccharide-induced activation of o-phenylenediamine oxidation by wheat seedlings in the presence of oxalic acid. | 2001-03 |
|
| An evaluation of the physicochemical risk for renal stone disease during pregnancy. | 2001-03 |
|
| Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives. | 2001-03 |
|
| Mediaeval cantorals in the Valladolid Biblioteca: FT-Raman spectroscopic study. | 2001-03 |
|
| Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones. | 2001-03 |
|
| Characterization of oxalate oxidase and cell death in Al-sensitive and tolerant wheat roots. | 2001-03 |
|
| Approaching zero discharge in uranium reprocessing: photochemical reduction of uranyl. | 2001-02-01 |
|
| Morphology and anatomy of developing fruits and seeds of Vismia guianensis (Aubl.) Choisy (Clusiaceae). | 2001-02 |
|
| Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model. | 2001-02 |
|
| The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index. | 2001-02 |
|
| Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes. | 2001-02 |
|
| Modelling of auxin-binding protein 1 suggests that its C-terminus and auxin could compete for a binding site that incorporates a metal ion and tryptophan residue 44. | 2001-02 |
|
| [Photooxidation of acridine orange in homogeneous system containing Fe3+ and H2O2 under visible irradiation]. | 2001-01 |
|
| Arsenic characterisation in industrial soils by chemical extractions. | 2001-01 |
|
| Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study. | 2001-01 |
|
| Improvement of a standard MIRA method for urinary oxalate by elimination of reagent carry-over. | 2001-01 |
|
| Automatic segmentation of medical images for renal calculi and analysis. | 2001 |
|
| Inhibition of potato polyphenol oxidase by anions and activity in various carboxylate buffers (pH 4.8) at constant ionic strength. | 2001 |
|
| Upregulation of the SERCA-type Ca2+ pump activity in response to endoplasmic reticulum stress in PC12 cells. | 2001 |
|
| A common carbanion intermediate in the recombination and proton-catalysed disproportionation of the carboxyl radical anion, CO2*-, in aqueous solution. | 2001 |
|
| The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. | 2001 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:54 GMT 2025
by
admin
on
Mon Mar 31 18:26:54 GMT 2025
|
| Record UNII |
9E7R5L6H31
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
13483-3
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
20927-0
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
EPA PESTICIDE CODE |
9601
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
34350-9
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
2699-7
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
2700-3
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
47715-8
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
27222-9
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
14861-9
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
57375-8
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
20928-8
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
57373-3
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
15085-4
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
26796-3
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
15086-2
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
57374-1
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
34349-1
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
49937-6
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
55961-7
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
WHO-VATC |
QP53AG03
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
14862-7
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
13788-5
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
||
|
LOINC |
2701-1
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
30623
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
SUB32959
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
DB03902
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
16995
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
m8280
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
9E7R5L6H31
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
1427058
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | RxNorm | ||
|
971
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
C84036
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
205-634-3
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
D019815
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
62774
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
1481215
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
OXALIC ACID
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
1441660
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
DTXSID0025816
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
144-62-7
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
9E7R5L6H31
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
100000125910
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY | |||
|
1100
Created by
admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
ASSAY (COLORIMETRIC)
USP
|
||
|
PARENT -> IMPURITY | |||
|
|
PARENT -> IMPURITY |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|